Sounds like a distraction to me. They're supposed to be focused on the high margin side of things, and this ain't it. I'd surely suspect that the take-up and prescription of these products would be multiples lower than that of cannabis so I see the upside.
At least the loan is on good terms so they're generating income from some of that cash.
Sounds like a distraction to me. They're supposed to be focused...
Add VIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $57.58M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.5¢ | 9.5¢ | $26.85K | 266.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 75704 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 161382 | 4 |
View Market Depth
| Last trade - 15.37pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.9¢ | 60571 | ||
| Last updated 15.37pm 17/06/2024 ? | |||||
| VIT (ASX) Chart |
